These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1892972)

  • 1. [The economic aspects of autologous blood transfusion using a prosthetic hip joint replacement as an example].
    Georgi R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Jun; 26(4):205-6. PubMed ID: 1892972
    [No Abstract]   [Full Text] [Related]  

  • 2. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
    Blumberg N; Kirkley SA; Heal JM
    Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.
    Healy JC; Frankforter SA; Graves BK; Reddy RL; Beck JR
    Arch Pathol Lab Med; 1994 Apr; 118(4):465-70. PubMed ID: 8166599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost analysis of autologous transfusion methods--a study of 5,017 patients].
    Singbartl G; Schleinzer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):350-8. PubMed ID: 10429773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical and cost efficiency of autologous blood donation in total hip or knee replacement].
    Willburger RE; Rüberg K; Knorth H; Casagranda O; Laubenthal H; Wiese M
    Z Orthop Ihre Grenzgeb; 2005; 143(3):360-4. PubMed ID: 15977128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of an autotransfusion program in primary knee and hip replacement surgery].
    Díaz-Espallardo C; Moral-García V
    Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):396-403. PubMed ID: 10613077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].
    Dietrich GV
    Zentralbl Chir; 1996; 121(10):841-6. PubMed ID: 9019932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of production costs of allogenic and autologous blood preservation].
    Diekamp U
    Beitr Infusionsther Transfusionsmed; 1994; 32():505-11. PubMed ID: 9480153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement.
    Birkmeyer JD; Goodnough LT; AuBuchon JP; Noordsij PG; Littenberg B
    Transfusion; 1993 Jul; 33(7):544-51. PubMed ID: 8333017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the analysis of the cost-effectiveness ratio for autologous transfusion programs].
    Moral García V; Díaz Espallardo C
    Rev Esp Anestesiol Reanim; 2001 May; 48(5):249-50. PubMed ID: 11412738
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost effectiveness of intraoperative autotransfusion in total hip arthroplasty surgery.
    Guerra JJ; Cuckler JM
    Clin Orthop Relat Res; 1995 Jun; (315):212-22. PubMed ID: 7634670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The short-term economic implications of prosthetic selection in hemiarthroplasty of the hip.
    Lavernia C; Lyon R
    Am J Orthop (Belle Mead NJ); 1998 Jun; 27(6):415-8. PubMed ID: 9652883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-anesthetic autologous blood donation used in knee and hip arthroplasty].
    Wei W; Kou B; Ju R
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):627-9. PubMed ID: 16827387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of recombinant erythropoietin in surgery--are the costs justified?].
    Wolff M; Fandrey J; Jelkmann W; Hirner A
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():143-5. PubMed ID: 9101815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous blood transfusion is preferable in orthopedic surgery].
    Fredin H; Elawad AA; Benoni G
    Lakartidningen; 1992 Feb; 89(9):637-8, 643-4. PubMed ID: 1538616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of the cost effectiveness ratio of an autotransfusion program for primary prosthetic knee and hip surgery].
    Muñoz Gómez M; García-Vallejo JJ; Clavero Barranquero A; López-Andrade Jurado A; Ruiz Romero de la Cruz MD
    Rev Esp Anestesiol Reanim; 2001 Jan; 48(1):43-4. PubMed ID: 11234608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autologous plasmapheresis].
    Mehrkens HH; Geiger P; Weindler M; Wollinsky KH; Pohland H
    Klin Anasthesiol Intensivther; 1993; 43():146-60. PubMed ID: 8421377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Marginal costs of total hip replacement--experiences from a county hospital department].
    Wedderkopp N; Mossing NB
    Ugeskr Laeger; 1995 Jan; 157(5):568-71. PubMed ID: 7638909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vertical pathway for total joint replacement.
    Mathias JM
    OR Manager; 1999 Apr; 15(4):27, 29-30, 32. PubMed ID: 10387262
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of autologous blood donation in orthopedic hip and knee joint replacement].
    Adams HA; Wittschier G; Fuhr R; Baltes-Götz B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 May; 32(5):283-90. PubMed ID: 9264615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.